Natpar - direct healthcare professional communication (DHPC)

parathyroid hormone

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Direct healthcare professional communication (DHPC): Natpar (parathyroid hormone): Discontinuation of manufacturing at the end of 2024 and update on 100mcg shortage

Dissemination date: 04/10/2022

Key facts

• Medicine name:
  Natpar
• Active substance:
  parathyroid hormone
• Therapeutic area (MeSH):
  Hypoparathyroidism
• Procedure number:
  EMEA/H/C/003861
• Regulatory outcome:
  Maintenance
• DHPC type:
  Medicine shortage
• Human ATC codes:
  H05AA03
• Dissemination date:
  04/10/2022